2006
DOI: 10.1002/pd.1601
|View full text |Cite
|
Sign up to set email alerts
|

Successful pregnancy outcome following maternal intravenous immunoglobulin treatment in a woman with recurrent perinatal haemochromatosis

Abstract: Haemochromatosis should be considered in the differential diagnosis of hydrops fetalis. The recurrence risk is high, and immunomodulation with intravenous immunoglobulin treatment appears to alter the course of the disease with better infant survival.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
8
0
2

Year Published

2007
2007
2017
2017

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 9 publications
1
8
0
2
Order By: Relevance
“…Others have reported similar success with this approach. [50][51][52][53] The success of this preventative therapy provides the impetus to make a diagnosis in any affected infant and stillbirth, so the family can have a healthy baby in the future.…”
Section: Preventionmentioning
confidence: 99%
“…Others have reported similar success with this approach. [50][51][52][53] The success of this preventative therapy provides the impetus to make a diagnosis in any affected infant and stillbirth, so the family can have a healthy baby in the future.…”
Section: Preventionmentioning
confidence: 99%
“…So, in addition to the several possible mechanisms of action cited above for alloimmune thrombocytopenia, inhibition of activation of the terminal complement cascade may be important in the action of antenatal IVIG therapy in GALD. Whatever the mechanism, wide experience suggests that it is effective in limiting the effect of GALD in pregnancies at risk [11,15,[21][22][23][24][25][26][27]. Although the extent of protection from fetal liver injury in GALD cannot be ascertained to the same degree as in alloimmune thrombocytopenia, where the platelet count is a direct measure of effectiveness, the results in the present study clearly demonstrate improved outcomes with IVIG treatment.…”
Section: Discussionmentioning
confidence: 52%
“…Parmi les nouveau-né s ayant pré senté une forme atté nué e d'HN, sept ont reçu un traitement mé dical associant ché lateur du fer et antioxydant ; aucun dé cè s n'est survenu. Ce travail a é té , par la suite, complé té par d'autres observations [27][28][29]. Dans notre é tude, deux nouveau-né s ont pré senté une forme biologique de la maladie, transitoire.…”
Section: Discussionunclassified